Evidence map›Paper›PMID 30796655›Full record

ArticleBreast cancer research and treatment2019

Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors.

Gitana Maria Aceto, Khalid Dafaallah Awadelkarim, Marta Di Nicola, Carmelo Moscatello, Mattia Russel Pantalone, Fabio Verginelli, Nasr Eldin Elwali, Renato Mariani-Costantini

Open access · hybridAbstract read
In one paragraph

Article in Breast cancer research and treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Gitana Maria AcetoDepartment of Medicine, Dentistry and Biotechnology, "G. d'Annunzio" University, Via dei Vestini 31, 66100, Chieti, Italy.
Khalid Dafaallah AwadelkarimDepartment of Molecular Biology, National Cancer Institute (NCI-UG), University of Gezira, P. O. Box 20, Wad Medani, Sudan.
Marta Di NicolaDepartment of Medicine, Dentistry and Biotechnology, "G. d'Annunzio" University, Via dei Vestini 31, 66100, Chieti, Italy.
Carmelo MoscatelloDepartment of Medicine, Dentistry and Biotechnology, "G. d'Annunzio" University, Via dei Vestini 31, 66100, Chieti, Italy.
Mattia Russel PantaloneDivision of Microbial Pathogenesis, Department of Medicine (Solna), BioClinicum, Karolinska Institutet, 17164, Stockholm, Sweden.
Fabio VerginelliDepartment of Pharmacy, "G. d'Annunzio" University, Via dei Vestini 31, 66100, Chieti, Italy.
Nasr Eldin ElwaliDepartment of Biochemistry, Faculty of Medicine, Imam Muhammad ibn Saud Islamic University, 7544 - Othman Bin Affan Rd. Al-Nada, Riyadh, 13317-4233, Saudi Arabia.
Renato Mariani-CostantiniDepartment of Medicine, Dentistry and Biotechnology, "G. d'Annunzio" University, Via dei Vestini 31, 66100, Chieti, Italy. rmc@unich.it.ORCID http://orcid.org/0000-0002-4440-1848
University of Chieti-Pescara · ITImam Mohammad ibn Saud Islamic University · SAKarolinska Institutet · SEUniversity of Gezira · SD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe role of non-genetic factors as modifiers of TP53-related hereditary breast cancer (BC) risk is debated. In this regard, little is known about the impact of germline TP53 mutations on BC in sub-Saharan Africa, where the disease often presents in non-contraceptive multiparous premenopausal women with extended history of breastfeeding. Herein, we report the germline TP53 mutations found in a series of 92 Sudanese premenopausal BC patients characterized for reproductive history.

methodsThe entire TP53 coding sequence, including intron-exon boundaries and UTRs, was analyzed via DHPLC and direct sequencing, and the association of TP53 genotypes with BC risk and with individual lifetime exposures to reproductive factors was investigated with statistical tools.

resultsThe germline TP53 mutation spectrum comprised 20 variants, 15 in the non-coding and 5 in the coding region. The latter included a deleterious missense mutation, c.817C>T (p.Arg273Cys), in a unique patient, and the common and functionally relevant coding polymorphism at amino acid 72 [Pro72Arg (rs1042522)]. The non-coding mutations included c.919+1G>A, a known deleterious splice site mutation, also in a unique patient. Notably, the 2 carriers of deleterious TP53 mutations clustered in the subset of cases with stronger reproductive history relative to childbearing age. When analyzed in comparison to population controls, the codon 72 polymorphism did not reveal associations with BC.

conclusionsOur study suggests that the codon 72 Arg>Pro polymorphism is not implicated in premenopausal BC susceptibility, whereas multiparity and breastfeeding might be BC risk factors for carriers of deleterious TP53 mutations.

Indexed as

Genetic Predisposition to DiseaseAdultBreast NeoplasmsFemaleGenetic TestingGenotypeGerm-Line MutationHeterozygoteHumansMiddle AgedParityPregnancyPremenopauseReproductionReproductive HistorySudanTP53 protein, humanTumor Suppressor Protein p53Breast cancerGermline mutationReproductive factorsSub-Saharan AfricaTP53

Identifiers

PMID30796655
PMCPMC6533225
OpenAlexW2917682530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.